Clot waveform analysis in acute promyelocytic leukemia

Area of Science:

• Hematology
• Clinical Chemistry
• Oncology

Background:

• Acute promyelocytic leukemia (APL) is associated with significant hemostatic abnormalities and bleeding risks.
• Current methods for assessing bleeding tendency in APL may not fully capture the complexity of coagulation.
• Clot waveform analysis (CWA) offers a dynamic approach to evaluating hemostasis.

Purpose of the Study:

• To evaluate the utility of activated partial thromboplastin time (APTT)-based and prothrombin time (PT)-based clot waveform analysis (CWA) in patients with acute promyelocytic leukemia (APL).
• To compare CWA parameters between APL patients and healthy volunteers.
• To correlate CWA parameters with disseminated intravascular coagulation (DIC) scores and fibrinogen levels in APL patients.

Main Methods:

• APTT and PT-based CWA were performed on APL patients and healthy volunteers.
• Key CWA parameters analyzed included maximum velocity (max1, max1') and acceleration (max2), along with their corresponding peak times (Tmax1, Tmax2).
• Statistical analysis involved Mann-Whitney U tests for comparisons and Spearman correlation tests for assessing relationships with DIC scores and fibrinogen levels.

Main Results:

• Tmax1 and Tmax2 were significantly prolonged in APL patients compared to healthy controls.
• While max1 and max2 were lower in APL patients, the difference was not statistically significant.
• Strong correlations were observed between CWA parameters (max1, max2, max1') and DIC scores, as well as fibrinogen levels.

Conclusions:

• APTT and PT-based CWA are valuable tools for assessing bleeding tendency in APL.
• CWA provides a novel method for evaluating global hemostasis and predicting bleeding risk in APL patients.
• These findings suggest CWA can improve the management of APL patients by offering better risk stratification.